Newswise — A unique symposium will gather national experts in genetics, medicine, bioinformatics, intellectual property, regulatory science, health economics and bioethics to examine the major scientific legal, economic and ethical questions surrounding precision medicine. Frontiers in Precision Medicine II: Cancer, Big Data and the Public will be held on Dec.1-2 at the University of Utah S.J. Quinney College of Law in Salt Lake City.
Sessions will explore tackling cancer with precision medicine, the ethics of access and precision medicine, patenting precision medicine and other issues. The symposium comes as increased national attention is being paid to precision medicine, including an initiative by Vice President Joe Biden’s known as “Cancer Moonshot,” which hopes to accelerate the cure for cancer using big data and precision oncology techniques.
The event’s keynote speaker will be Christopher P. Austin, M.D., director of the National Center for Advancing Translational Sciences (NCATS) at the National Institutes of Health (NIH). Austin leads the center’s work to improve the translation of observations in the laboratory, clinic and community into interventions that reach and benefit patients — from diagnostics and therapeutics to medical procedures and behavioral changes. Under his direction, NCATS researchers and collaborators are developing new technologies, resources and collaborative research models; demonstrating their usefulness; and disseminating the data, analysis and methodologies for use by the worldwide research community. Austin speaks on Dec.1 at 1:20 p.m. MST. The event will also be live streamed and can be accessed through the following links:• Thursday, December 1, 2016 morning session »• Thursday, December 1, 2016 afternoon session »• Friday, December 2, 2016 morning session »
RSS